BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10499732)

  • 21. Endoscopic evaluation of etodolac and naproxen, and their relative effects on gastric and duodenal prostaglandins.
    Russell RI
    Rheumatol Int; 1990; 10 Suppl():17-21. PubMed ID: 2150567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of zinc-L-carnosine and vitamin E on aspirin-induced gastroduodenal injury in dogs.
    Baan M; Sherding RG; Johnson SE
    J Vet Intern Med; 2011; 25(1):39-46. PubMed ID: 21092006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Etodolac, a new nonsteroidal anti-inflammatory drug: gastrointestinal microbleeding and endoscopic studies.
    Lanza FL; Arnold JD
    Clin Rheumatol; 1989 Mar; 8 Suppl 1():5-15. PubMed ID: 2525983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of dosing and sampling time on serum thyroxine, free thyroxine, and thyrotropin concentrations in dogs following multidose etodolac administration.
    Ness TA; Torres SM; Kramek EA; Blauvelt MM
    Vet Ther; 2003; 4(4):340-9. PubMed ID: 15136976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonsteroidal antiinflammatory drugs: a review.
    Curry SL; Cogar SM; Cook JL
    J Am Anim Hosp Assoc; 2005; 41(5):298-309. PubMed ID: 16141181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Double-blind comparison of the efficacy and safety of etodolac SR 600 mg u.i.d. and of tenoxicam 20 mg u.i.d. in elderly patients with osteoarthritis of the hip and of the knee.
    Perpignano G; Bogliolo A; Puccetti L
    Int J Clin Pharmacol Res; 1994; 14(5-6):203-16. PubMed ID: 7672877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Power of treatment success definitions when the Canine Brief Pain Inventory is used to evaluate carprofen treatment for the control of pain and inflammation in dogs with osteoarthritis.
    Brown DC; Bell M; Rhodes L
    Am J Vet Res; 2013 Dec; 74(12):1467-73. PubMed ID: 24274882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical evaluation of firocoxib and carprofen for the treatment of dogs with osteoarthritis.
    Pollmeier M; Toulemonde C; Fleishman C; Hanson PD
    Vet Rec; 2006 Oct; 159(17):547-51. PubMed ID: 17056650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects on gastroduodenal mucosa of a new nonsteroidal anti-inflammatory drug, amtolmetin-guacyl, versus piroxicam in healthy volunteers: a short-term, double-blind, endoscopically controlled study.
    Lazzaroni M; Anderloni A; Bianchi Porro G
    Eur J Gastroenterol Hepatol; 2001 Jul; 13(7):833-9. PubMed ID: 11474314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of etodolac for the treatment of osteoarthritis of the hip joints in dogs.
    Budsberg SC; Johnston SA; Schwarz PD; DeCamp CE; Claxton R
    J Am Vet Med Assoc; 1999 Jan; 214(2):206-10. PubMed ID: 9926009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Robenacoxib vs. carprofen for the treatment of canine osteoarthritis; a randomized, noninferiority clinical trial.
    Reymond N; Speranza C; Gruet P; Seewald W; King JN
    J Vet Pharmacol Ther; 2012 Apr; 35(2):175-83. PubMed ID: 21480932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of combined carprofen and omeprazole administration on gastrointestinal permeability and inflammation in dogs.
    Jones SM; Gaier A; Enomoto H; Ishii P; Pilla R; Price J; Suchodolski J; Steiner JM; Papich MG; Messenger K; Tolbert MK
    J Vet Intern Med; 2020 Sep; 34(5):1886-1893. PubMed ID: 32893926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ability of the canine brief pain inventory to detect response to treatment in dogs with osteoarthritis.
    Brown DC; Boston RC; Coyne JC; Farrar JT
    J Am Vet Med Assoc; 2008 Oct; 233(8):1278-83. PubMed ID: 19180716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Aspirin and gastroduodenal toxicity. A double-blind endoscopic study of the effects of placebo, aspirin and lysine acetylsalicylate in healthy subjects].
    Bretagne JF; Feuillu A; Gosselin M; Gastard J
    Gastroenterol Clin Biol; 1984 Jan; 8(1):28-32. PubMed ID: 6698337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Canine Orthopedic Index. Step 3: Responsiveness testing.
    Brown DC
    Vet Surg; 2014 Mar; 43(3):247-54. PubMed ID: 24617818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Etodolac, aspirin, and placebo in patients with degenerative joint disease: a twelve-week study.
    Andelman SY
    Clin Ther; 1983; 5(6):651-61. PubMed ID: 6226358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in platelet function, hemostasis, and prostaglandin expression after treatment with nonsteroidal anti-inflammatory drugs with various cyclooxygenase selectivities in dogs.
    Brainard BM; Meredith CP; Callan MB; Budsberg SC; Shofer FS; Driessen B; Otto CM
    Am J Vet Res; 2007 Mar; 68(3):251-7. PubMed ID: 17331013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of force plate gait analysis and owner assessment of pain using the Canine Brief Pain Inventory in dogs with osteoarthritis.
    Brown DC; Boston RC; Farrar JT
    J Vet Intern Med; 2013; 27(1):22-30. PubMed ID: 23311715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of the homeopathic preparation Zeel compared with carprofen in dogs with osteoarthritis.
    Neumann S; Stolt P; Braun G; Hellmann K; Reinhart E
    J Am Anim Hosp Assoc; 2011; 47(1):12-20. PubMed ID: 21164168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suspected carprofen toxicosis caused by coprophagia in a dog.
    Hutchins RG; Messenger KM; Vaden SL
    J Am Vet Med Assoc; 2013 Sep; 243(5):709-11. PubMed ID: 23971852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.